First Cited
Last Cited

Articles citing This Document (Page 1 of 1)

Direct oral anticoagulants toxicity in children: an overview and practical guide
Development and validation of capillary zone electrophoresis and high-performance liquid chromatography methods for the determination of oral anticoagulant Edoxaban in pharmaceutical tablets.Electrophoresis2022
Monitoring of Direct Oral Anticoagulants Plasma Levels for Secondary Stroke Prevention.Journal of Thrombosis and Haemostasis2022
Use of statins, amiodarone, direct oral anticoagulants and NSAIDs in chronic liver disease: a guide for general cliniciansRomanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne2020
Antithrombotika und Antihämorrhagika2020
Oral anticoagulants: Optimizing venous thromboembolism managementJournal of Applied Hematology2019
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trialJournal of Clinical Neuroscience2021
Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysisCardiovascular Drugs and Therapy2021
Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation and (Morbid) Obesity or Low Body Weight: a Systematic Review and Meta-AnalysisCardiovascular Drugs and Therapy2021
Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative ReviewAdvances in Therapy2020
Simple LC-MS/MS method using core-shell ODS microparticles for the simultaneous quantitation of edoxaban and its major metabolites in human plasmaJournal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences2020
Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational studyBMC Medicine2020
Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomesJournal of Thrombosis and Thrombolysis2020
Cardiovascular Risk Management and Hepatitis C: Combining DrugsClinical Pharmacokinetics2019
Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapyJournal of Nephrology2019
Consensus in cardiology on non-vitamin-K oral anticoagulants for patients with atrial fibrillationCurrent Medical Research and Opinion2019
Appropriateness of dabigatran dosing in patients with nonvalvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the eastern province of Saudi ArabiaJournal of the Saudi Heart Association2019
Emergency Reversal of AnticoagulationWestern Journal of Emergency Medicine2019
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney DiseaseClinical Journal of the American Society of Nephrology: CJASN2019
Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and SafetyJournal of the American College of Cardiology2018
Oral Anticoagulation in Patients With Liver DiseaseJournal of the American College of Cardiology2018
Anticoagulation ReversalEmergency Medicine Clinics of North America2018
Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE studyBJOG: an International Journal of Obstetrics and Gynaecology2018
Impact of Renal Function on Outcomes With Edoxaban in Real-World Patients With Atrial FibrillationStroke2018
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial FibrillationSeminars in Nephrology2018
Augmented Renal Clearance in Critically Ill Patients: A Systematic ReviewClinical Pharmacokinetics2018
Quality of direct oral anticoagulant prescribing in elderly patients with non-valvular atrial fibrillation: results from a large urban health systemJournal of Thrombosis and Thrombolysis2018
Review: An overview and analysis of novel oral anticoagulants and their dental implicationsGerodontology2018
Pulmonary embolism four days after interruption of therapy with rivaroxabanHamostaseologie2017
Monitoring and Reversal of Oral Anticoagulation in Hospitalized PatientsHospital Medicine Clinics2017
Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral AnticoagulantsTechniques in Vascular and Interventional Radiology2017
Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover studyJournal of Thrombosis and Haemostasis2017
Anti-thrombotic therapy for atrial fibrillation in patients with chronic kidney disease: Current viewsHemodialysis International2017
Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillationHeart2017
Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical GuidanceAmerican Journal of Medicine2017
Edoxaban in Atrial Fibrillation and Venous Thromboembolism-Ten Key Questions and Answers: A Practical GuideAdvances in Therapy2017
[Vitamin K antagonists : Is their prescription really "medical malpractice" today?]Der Internist2017
2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task ForceJournal of the American College of Cardiology2017
Pharmacokinetics and Pharmacodynamics of the Nonvitamin K Antagonist Oral Anticoagulant Edoxaban When Administered Alone or After Switching from Rivaroxaban or Dabigatran Etexilate in Healthy SubjectsClinical Drug Investigation2016
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialCirculation2016
Creatinine Clearance Is Not Equal to Glomerular Filtration Rate and Cockcroft-Gault Equation Is Not Equal to CKD-EPI Collaboration EquationAmerican Journal of Medicine2016
Direct Oral Anticoagulants in CirrhosisCurrent Treatment Options in Gastroenterology2016
Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guideThrombosis and Haemostasis2016
Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical PracticeDrugs2015
Considerations for Systemic Anticoagulation in ESRDSeminars in Dialysis2015
Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectivesEuropean Journal of Haematology2015